|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder | |||||||
| 化学式 | C14H21N3O |
||||||||||
| 分子量 | 247.34 | CAS No. | 146986-50-7 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | 49 mg/mL (198.1 mM) | ||||||||
| Ethanol | 49 mg/mL (198.1 mM) | ||||||||||
| Water | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | Y-27632 is a selective ROCK1 and ROCK2 inhibitor with a Ki of 140 nM and 300nM in a cell-free assay, exhibits >200-fold selectivity over other kinases, including PKC, cAMP-dependent protein kinase, MLCK and PAK. |
|---|---|
| in vitro | Y-27632 primes human induced pluripotent stem cells (hIPSCs) to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation.[2] |
| in vivo | Y27632, a specific inhibitor of ROCK, supresses ROCK as well as altered pathways and leads to a significant enhancement in corneal nerve regeneration.[3] |
| 細胞アッセイ | 細胞株 | Human iPSC line nciPS02, RC01001-B, Female; Pluripotent stem cells |
|---|---|---|
| 濃度 | 20 µM | |
| 反応時間 | -- | |
| 実験の流れ | The hiPSC line is cultured on six-well plates coated with 1% Matrigel. Pluripotent stem cells are maintained in mTeSR1 (Stem Cell) medium supplemented with 100 µg/mL Normocin coated with 1% Matrigel. For differentiation, hiPSC colonies are detached from the culture dish using Accutase Cell Dissociation Reagent. Then, cells are collected as a single-cell suspension in Essential 8 Flex medium containing 20 µm Y27632. Cells are distributed at a density of 3500 cells in 100 µL of medium per well into 96-well U-bottom plates. After 24 h of incubation at 37 ℃, fresh E8 medium without Y27632 is added to a total volume of 200 µL per well, and the plates are incubated at 37℃ continuously. Next, cell aggregates are cultured in E6-based differentiation medium containing 2% Matrigel, 10 µm SB431542, 4 ng mL 1 basic FGF, and 2.5 ng mL 1 BMP4. On day 3 of differentiation, 200 ng mL 1 LDN-193189 and 50 g mL 1 FGF are added to induce cranial neural crest cell formation. On day 12, all cell aggregates are transferred to 24-well low-attachment plates in 500 µL of organoid maturation mediumcontaining 1% Matrigel to induce self-assembly of the epidermis. Half of the medium is replaced after 16 d after differentiation. On day 17, the organoids are collected for the subsequent experiments. |
|
| 動物実験 | 動物モデル | C57BL/6J mice |
| 投薬量 | 5 nM | |
| 投与方法 | eye drops |
|
| Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition [ Science, 2025, 388(6747):eadk3487] | PubMed: 40339010 |
| Derivation of embryonic stem cells across avian species [ Nat Biotechnol, 2025, 10.1038/s41587-025-02833-3] | PubMed: 41028831 |
| Olmesartan Restores LMNA Function in Haploinsufficient Cardiomyocytes [ Circulation, 2025, 151(20):1436-1448] | PubMed: 40166828 |
| Olmesartan Restores LMNA Function in Haploinsufficient Cardiomyocytes [ Circulation, 2025, 151(20):1436-1448] | PubMed: 40166828 |
| Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24 [ Mol Cancer, 2025, 24(1):197] | PubMed: 40676628 |
| The integrated stress response fine-tunes stem cell fate decisions upon serine deprivation and tissue injury [ Cell Metab, 2025, 37(8):1715-1731.e11] | PubMed: 40513561 |
| Mechano-osmotic signals control chromatin state and fate transitions in pluripotent stem cells [ Nat Cell Biol, 2025, 27(10):1757-1770] | PubMed: 41023488 |
| A novel organoid model retaining the glioma microenvironment for personalized drug screening and therapeutic evaluation [ Bioact Mater, 2025, 53:205-217] | PubMed: 40697395 |
| Highly efficient construction of monkey blastoid capsules from aged somatic cells [ Nat Commun, 2025, 16(1):1130] | PubMed: 39875393 |
| Frictiotaxis underlies focal adhesion-independent durotaxis [ Nat Commun, 2025, 16(1):3811] | PubMed: 40268931 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。